You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 252 Immune-related adverse events associated with immune checkpoint inhibitor therapy are associated with enhanced survival and disease-specific incidence

Alerts

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Checkpoint blockade therapy
252 Immune-related adverse events associated with immune checkpoint inhibitor therapy are associated with enhanced survival and disease-specific incidence
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address